Status:
UNKNOWN
Immune Response Following Lobectomy Along With or Without Bilateral Transcervical Mediastinal Lymphadenectomy
Lead Sponsor:
Otto Wagner Hospital
Collaborating Sponsors:
Medtronic Spine LLC
Conditions:
Lung Neoplasm Malignant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Any kind of anatomical lung resection for lung cancer with curative intent has to be accompanied by formal mediastinal lymph node dissection. Video-assisted mediastinoscopic lymphadenectomy through a ...
Detailed Description
Any kind of anatomical lung resection for lung cancer with curative intent has to be accompanied by formal mediastinal lymph node dissection. Video-assisted mediastinoscopic lymphadenectomy through a ...
Eligibility Criteria
Inclusion
- adult
- non small cell lung cancer
- operable tumor
- indicated for endoscopic lung surgery
Exclusion
- pregnancy
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04778826
Start Date
October 1 2020
End Date
March 1 2023
Last Update
March 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Thoracic Surgery, clinic Floridsdorf
Vienna, Austria, 1210